According to our (Global Info Research) latest study, the global Immunopeptidome Profiling market size was valued at US$ 437 million in 2025 and is forecast to a readjusted size of US$ 759 million by 2032 with a CAGR of 8.3% during review period.
The immunopeptidome refers to the study of all peptides presented by nucleated cells on MHC-Class I or II proteins (Major Histocompatibility Complex, also known as the major histocompatibility complex, such as the expression product of human MHC, HLA, Human Leukocyte Antigen) involved in the antigen presentation pathway, and is essential for the investigation of immunogenic epitopes in cell-mediated and humoral responses.Immunopeptidome profiling is the study of the dynamics and composition of class I and II immune peptides, enabling not only the discovery of targets for personalized cancer immunotherapy (such as neoantigens from tumor-specific mutations or tumor-associated antigens), but also contributes to new mRNA/polypeptide vaccines and immune cell therapy.
This report is a detailed and comprehensive analysis for global Immunopeptidome Profiling market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immunopeptidome Profiling market size and forecasts, in consumption value ($ Million), 2021-2032
Global Immunopeptidome Profiling market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Immunopeptidome Profiling market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Immunopeptidome Profiling market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immunopeptidome Profiling
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immunopeptidome Profiling market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biognosys, Creative Dynamics Inc (Creative Proteomics), Cayman Chemical Company, Evotec, Helmholtz Munich, Bioinformatics Solutions Inc., Beijing Qinglian Baiao Biotechnology, Biotech Pack, Wininnovate Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Immunopeptidome Profiling market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Type I Peptides
Type II Peptides
Market segment by Application
Vaccine Development
Cancer Immunotherapy
Market segment by players, this report covers
Biognosys
Creative Dynamics Inc (Creative Proteomics)
Cayman Chemical Company
Evotec
Helmholtz Munich
Bioinformatics Solutions Inc.
Beijing Qinglian Baiao Biotechnology
Biotech Pack
Wininnovate Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immunopeptidome Profiling product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immunopeptidome Profiling, with revenue, gross margin, and global market share of Immunopeptidome Profiling from 2021 to 2026.
Chapter 3, the Immunopeptidome Profiling competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immunopeptidome Profiling market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunopeptidome Profiling.
Chapter 13, to describe Immunopeptidome Profiling research findings and conclusion.
Summary:
Get latest Market Research Reports on Immunopeptidome Profiling. Industry analysis & Market Report on Immunopeptidome Profiling is a syndicated market report, published as Global Immunopeptidome Profiling Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Immunopeptidome Profiling market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.